Actionable insights straight to your inbox

logo_equities.svg

Tango Merger Sub 2 LLC Files SEC Form POS AM, Post-effective Amendments For Registration Statement (Jul. 1, 2014)

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Tango Merger Sub 2 LLC (Form POS AM) was posted on July 1, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There was one document filed with this form. The SEC file number is 0001193125-14-256922.
The contact information for this company is 909 THIRD AVENUE, NEW YORK NY 10022, (212)421-7850.
Our editors provided additional information about Form POS AM: Post-effective amendments.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/38074/0001193125-14-256922-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Tango Merger Sub 2 LLC, Mergers and Acquisitions.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

Many people think of position size in terms of how many shares they own of a particular stock. But it’s much smarter to think of it in terms of what percentage of your total capital is in a particular stock.